SCHEMBL538293

SCHEMBL538293

c1ccc(CONOCc2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.57
IDO1 P14902 1/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
AGXT P21549 1/20 0.50
HRAS P01112 1/20 0.46
BCHE P06276 1/20 0.43
ALDH1A1 P00352 3/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
PTGS1 P23219 1/20 0.43
SLC6A2 P23975 1/20 0.43
CYP2C19 P33261 1/20 0.43
PTGS2 P35354 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HIF1A Q16665 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11220071 0.97 TSHR (0.55) TSHRIDO1NPC1RAB9AAGXT
SCHEMBL18541671 0.85 TSHR (0.48) TSHRIDO1NPC1RAB9AAGXT
SCHEMBL28510963 0.79 TSHR (0.52) TSHRIDO1NPC1RAB9AAGXT
SCHEMBL8863647 0.79 IDO1 (0.54) TSHRIDO1NPC1RAB9AAGXT
SCHEMBL4695833 0.79 NPC1 (0.53) TSHRIDO1NPC1RAB9AAGXT
SCHEMBL4744780 0.79 TSHR (0.52) TSHRIDO1NPC1RAB9AAGXT
SCHEMBL4589000 0.79 TSHR (0.52) TSHRIDO1NPC1RAB9AAGXT
Hydrochloric Acid SCHEMBL3588939 0.77 NPC1 (0.52) TSHRIDO1NPC1RAB9AAGXT
SCHEMBL206646 0.77 HRAS (0.65) TSHRIDO1NPC1RAB9AAGXT
SCHEMBL311949 0.77 TSHR (0.50) TSHRIDO1NPC1RAB9AAGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1718271-B1 STABILIZED BODY CARE PRODUCTS, HOUSEHOLD PRODUCTS BASF SE (DE) 2014-10-08 EP claimed
EP-3658616-B1 HALOGEN-FREE SULPHONIC ACID ESTER AND/OR SULPHINIC ACID ESTER AS FLAME RETARDANT, FLAME RETARDANT SYNERGISTS AND RADICAL GENERATORS IN PLASTICS FRAUNHOFER GES FORSCHUNG (DE) 2025-10-22 EP disclosed
WO-2025217099-A1 INHIBITORS FOR HYDROGEN EMBRITTLEMENT AND METHODS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-16 WO disclosed
US-20240050438-A1 BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE ATHENEX, INC. 2024-02-15 US disclosed
EP-3710424-B1 COMPOUNDS HAVING A STABILIZING EFFECT, METHOD FOR PRODUCING SAID COMPOUNDS, COMPOSITION CONTAINING SAID STABILIZING COMPOUNDS, METHOD FOR STABILIZING AN ORGANIC COMPONENT, AND USE OF STABILIZING COMPOUNDS FRAUNHOFER GES FORSCHUNG (DE) 2024-01-03 EP disclosed
EP-4028382-B1 QUINONE METHIDE AND AMMONIUM SALT ANTIPOLYMERANT COMPOSITION AND METHOD ECOLAB USA INC (US) 2023-11-22 EP disclosed
EP-3194487-B1 USE OF ORGANIC OXYIMIDES AS RADICAL GENERATORS IN PLASTICS, METHOD FOR GENERATING RADICALS IN PLASTICS AND USE OF SAID METHOD FRAUNHOFER GES FORSCHUNG (DE) 2022-11-02 EP disclosed
US-11396629-B2 Quinone methide and ammonium salt antipolymerant composition and method ECOLAB USA INC. (US) 2022-07-26 US disclosed
US-20220119347-A1 BIARYL COMPOSITIONS IN COMBINATION WITH TAMOXIFEN AND METHODS FOR MODULATING A KINASE CASCADE SAGARD HEALTHCARE ROYALTY PARTNERS, LP, AS ADMINISTRATIVE AGENT (CA) 2022-04-21 US disclosed
US-20210252008-A1 BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE SAGARD HEALTHCARE ROYALTY PARTNERS, LP, AS ADMINISTRATIVE AGENT (CA) 2021-08-19 US disclosed
EP-1572817-A1 INK-JET INK AND RECORDING MATERIAL Ciba SC Holding AG (CH) 2005-09-14 EP disclosed
WO-2004056931-A1 INK-JET INK AND RECORDING MATERIAL CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-07-08 WO disclosed
EP-1373395-A2 PROCESS FOR PREPARING A STABILIZED POLYESTER Ciba SC Holding AG (CH) 2004-01-02 EP disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2002079310-A2 PROCESS FOR PREPARING A STABILIZED POLYESTER CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-10-10 WO disclosed
EP-1131483-A1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES Ciba SC Holding AG (CH) 2001-09-12 EP disclosed
WO-2000024963-A1 INHIBITION OF PULP AND PAPER YELLOWING USING HYDROXYLAMINES AND OTHER COADDITIVES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-05-04 WO disclosed
US-6031130-A CATALYZING THE DEHYDRATION OF A SECONDARY AMINE COMPOUND BY ADDING A RHENIUM CATALYST AND AQUEOUS HYDROGEN PEROXIDE TO A MIXTURE ALSO CONTAINING A DEHYDRATING AGENT; USE AS PHOTOGRAPHIC DEVELOPERS, ADDITIVES FOR POLYMERS FUJI PHOTO FILM CO., LTD. (JP) 2000-02-29 US disclosed
EP-0389419-A1 Non-migrating 1-hydrocarbyloxy hindered amine compounds as polymer stabilizers CIBA-GEIGY AG (CH) 1990-09-26 EP disclosed
EP-0240297-A1 Inhibiting polymerization of vinyl aromatic compounds BETZ EUROPE, INC. (US) 1987-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119347-A1 BIARYL COMPOSITIONS IN COMBINATION WITH TAMOXIFEN AND METHODS FOR MODULATING A KINASE CASCADE MAP3K2, MAP3K6, MAP3K8 TSHR 2031/4885IDO1 4539/4885NPC1 3031/4885
US-20240050438-A1 BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE MAP3K3, MAP3K2, MAP3K20 TSHR 3706/4885IDO1 4192/4885NPC1 2695/4885
US-11396629-B2 Quinone methide and ammonium salt antipolymerant composition and method SQOR, QDPR, NQO2 TSHR 4552/4885IDO1 2350/4885NPC1 4833/4885
US-20210252008-A1 BIARYL COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE MAP3K3, MAP3K2, MAP3K20 TSHR 3706/4885IDO1 4192/4885NPC1 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.